NCT06136741View on ClinicalTrials.gov

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

396

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

May 6, 2025

Study Completion Date

December 31, 2026

Conditions
Moderate to Severe Atopic Dermatitis
Interventions
DRUG

Rezpegaldesleukin

Pharmaceutical form: Injection solution Route of administration: subcutaneous

DRUG

Placebo

Pharmaceutical form: Injection solution Route of administration: subcutaneous

Trial Locations (107)

1407

Nektar Investigative Site, Sofia

1431

Nektar Investigative Site, Sofia

1463

Nektar Investigative Site, Sofia

1510

Nektar Investigative Site, Sofia

1592

Nektar Investigative Site, Sofia

1784

Nektar Investigative Site, Sofia

2010

Nektar Investigative Site, Darlinghurst

2145

Nektar Investigative Site, Westmead

2217

Nektar Investigative Site, Kogarah

2600

Nektar Investigative Site, Dupnitsa

3002

Nektar Investigative Site, East Melbourne

3004

Nektar Investigative Site, Melbourne

3010

Nektar Investigative Site, Alicante

4102

Nektar Investigative Site, Woolloongabba

4103

Nektar Investigative Site, Leipzig

5074

Nektar Investigative Site, Campbelltown

5400

Nektar Investigative Site, Sevlievo

5500

Nektar Investigative Site, Lovech

5700

Nektar Investigative Site, Gyula

5800

Nektar Investigative Site, Pleven

10000

Nektar Investigative Site 5701, Zagreb

Nektar Investigative Site 5703, Zagreb

10075

Nektar Investigative Site, New York

10310

Nektar Investigative Site, Ivanić-Grad

10789

Nektar Investigative Site, Berlin

13353

Nektar Investigative Site, Berlin

14004

Nektar Investigative Site, Córdoba

18014

Nektar Investigative Site, Granada

23538

Nektar Investigative Site, Lübeck

30060

Nektar Investigative Site, Marietta

33014

Nektar Investigative Site, Miami Lakes

33016

Nektar Investigative Site, Hialeah

33021

Nektar Investigative Site, Hollywood

33173

Nektar Investigative Site, Miami

33615

Nektar Investigative Site, Tampa

33705

Nektar Investigative Site, St. Petersburg

37130

Nektar Investigative Site, Murfreesboro

40241

Nektar Investigative Site, Louisville

41009

Nektar Investigative Site, Seville

44124

Nektar Investigative Site, Mayfield Heights

45324

Nektar Investigative Site, Fairborn

46202

Nektar Investigative Site, Indianapolis

47129

Nektar Investigative Site, Clarksville

48084

Nektar Investigative Site, Troy

48455

Nektar Investigative Site, Bad Bentheim

48532

Nektar Investigative Site, Flint

50009

Nektar Investigative Site, Zaragoza

55131

Nektar Investigative Site, Mainz

60590

Nektar Investigative Site, Frankfurt

64283

Nektar Investigative Site, Darmstadt

72022

Nektar Investigative Site, Bryant

75034

Nektar Investigative Site, Frisco

77401

Nektar Investigative Site, Bellaire

77429

Nektar Investigative Site, Cypress

80337

Nektar Investigator Site, München

86150

Nektar Investigative Site, Augsburg

86179

Nektar Investigator Site, Augsburg

89106

Nektar Investigative Site, Las Vegas

90017

Nektar Investigative Site, Los Angeles

90025

Nektar Investigative Site, Los Angeles

90057

Nektar Investigative Site, Los Angeles

90404

Nektar Investigative Site, Santa Monica

91054

Nektar Investigative Site, Erlangen

92708

Nektar Investigative Site, Fountain Valley

99202

Nektar Investigative Site, Spokane

99202-1461

Nektar Investigative Site, Spokane

T2J 7E1

Nektar Investigative Site, Calgary

T6H 4J8

Nektar Investigative Site, Edmonton

V1W 4V5

Nektar Investigative Site, Kelowna

V3V 0C6

Nektar Investigative Site, Surrey

L4M 7G1

Nektar Investigative Site, Barrie

L3P 1X3

Nektar Investigative Site, Markham

K9J 5K2

Nektar Investigative Site, Peterborough

L4B 1A5

Nektar Investigative Site, Richmond Hill

M3H 5Y8

Nektar Investigative Site, Toronto

M4W 2N2

Nektar Investigative Site, Toronto

G1W 4R4

Nektar Investigative Site, Québec

602 00

Nektar Investigative Site, Brno

530 02

Nektar Investigative Site, Pardubice

100 34

Nektar Investigative Site, Prague

150 00

Nektar Investigative Site, Prague

50-220

Nektar Investigative Site, Wroclaw

50-381

Nektar Investigative Site, Wroclaw

51-685

Nektar Investigative Site, Wroclaw

00-874

Nektar Investigative Site, Warsaw

02-672

Nektar Investigative Site, Warsaw

02-953

Nektar Investigative Site, Warsaw

35-055

Nektar Investigative Site, Rzeszów

80-382

Nektar Investigative Site, Gdansk

80-546

Nektar Investigative Site, Gdansk

81-537

Nektar Investigative Site, Gdynia

42-202

Nektar Investigative Site, Częstochowa

14-200

Nektar Investigative Site, Iława

40-040

Nektar Investigative Site, Katowice

30-033

Nektar Investigator Site, Krakow

30-727

Nektar Investigative Site, Krakow

31-011

Nektar Investigative Site, Krakow

90-127

Nektar Investigative Site, Lodz

90-436

Nektar Investigative Site, Lodz

60-702

Nektar Investigative Site, Poznan

71-500

Nektar Investigative Site, Szczecin

33-100

Nektar Investigative Site, Tarnów

01-142

Nektar Investigative Site, Warsaw

02-507

Nektar Investigative Site, Warsaw

02-962

Nektar Investigative Site, Warsaw

50-566

Nektar Investigative Site, Wroclaw

51-503

Nektar Investigative Site, Wroclaw

Sponsors
All Listed Sponsors
lead

Nektar Therapeutics

INDUSTRY

NCT06136741 - A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis | Biotech Hunter | Biotech Hunter